David Damoiseaux

In October 2019, I joined the Beijnen group as a PhD student. Here, my project focuses on population pharmacokinetic and physiologically based pharmacokinetic modeling with anticancer therapies. This project will consist of two tracks: exposure of oncolytic agents in human breast milk and preclinical study designs.